BlackRock’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,790
| Closed | -$4.65K | – | 5478 |
|
|
2023
Q3 | $4.65K | Hold |
4,790
| – | – | ﹤0.01% | 5249 |
|
|
2023
Q2 | $3.36K | Hold |
4,790
| – | – | ﹤0.01% | 5340 |
|
|
2023
Q1 | $3.16K | Hold |
4,790
| – | – | ﹤0.01% | 5416 |
|
|
2022
Q4 | $7.19K | Hold |
4,790
| – | – | ﹤0.01% | 5495 |
|
|
2022
Q3 | $9K | Sell |
4,790
-3
| -0.1% | -$9 | ﹤0.01% | 5598 |
|
|
2022
Q2 | $27K | Hold |
4,793
| – | – | ﹤0.01% | 5518 |
|
|
2022
Q1 | $57K | Hold |
4,793
| – | – | ﹤0.01% | 5396 |
|
|
2021
Q4 | $49K | Buy |
4,793
+3,381
| +239% | +$60.7K | ﹤0.01% | 5405 |
|
|
2021
Q3 | $46K | Buy |
1,412
+577
| +69% | +$18.7K | ﹤0.01% | 5289 |
|
|
2021
Q2 | $36K | Sell |
835
-152
| -15% | -$6.25K | ﹤0.01% | 5230 |
|
|
2021
Q1 | $48K | Hold |
987
| – | – | ﹤0.01% | 4923 |
|
|
2020
Q4 | $35K | Hold |
987
| – | – | ﹤0.01% | 4714 |
|
|
2020
Q3 | $40K | Hold |
987
| – | – | ﹤0.01% | 4635 |
|
|
2020
Q2 | $44K | Hold |
987
| – | – | ﹤0.01% | 4599 |
|
|
2020
Q1 | $53K | Hold |
987
| – | – | ﹤0.01% | 4459 |
|
|
2019
Q4 | $66K | Sell |
987
-95
| -9% | -$11K | ﹤0.01% | 4502 |
|
|
2019
Q3 | $203K | Buy |
1,082
+1
| +0.1% | +$230 | ﹤0.01% | 4326 |
|
|
2019
Q2 | $290K | Sell |
1,081
-167
| -13% | -$56K | ﹤0.01% | 4292 |
|
|
2019
Q1 | $472K | Sell |
1,248
-10
| -0.8% | -$3.35K | ﹤0.01% | 4108 |
|
|
2018
Q4 | $467K | Sell |
1,258
-2
| -0.2% | -$785 | ﹤0.01% | 4078 |
|
|
2018
Q3 | $544K | Buy |
1,260
+8
| +0.6% | +$3.37K | ﹤0.01% | 4124 |
|
|
2018
Q2 | $453K | Buy |
1,252
+209
| +20% | +$98.4K | ﹤0.01% | 4126 |
|
|
2018
Q1 | $476K | Sell |
1,043
-7
| -0.7% | -$3.48K | ﹤0.01% | 4055 |
|
|
2017
Q4 | $605K | Hold |
1,050
| – | – | ﹤0.01% | 4025 |
|
|
2017
Q3 | $794K | Buy |
1,050
+2
| +0.2% | +$1.58K | ﹤0.01% | 3972 |
|
|
2017
Q2 | $879K | Sell |
1,048
-109
| -9% | -$79.7K | ﹤0.01% | 3878 |
|
|
2017
Q1 | $817K | Buy |
+1,157
| New | +$816K | ﹤0.01% | 3853 |
|
|
2013
Q4 | – | Sell |
-1
| Closed | -$3K | – | 3149 |
|
|
2013
Q3 | $3K | Hold |
1
| – | – | ﹤0.01% | 3066 |
|
|
2013
Q2 | $7K | Buy |
+1
| New | +$11.1K | ﹤0.01% | 2888 |
|
Other funds holding FRTX
BlackRock's FRTX Position: Q4 2023 in Review
BlackRock sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2023, closing a stake of 4,790 shares — an estimated $4.65K sold.
BlackRock first reported a position in FRTX in Q2 2013 and held it in 29 quarters. The position peaked at $879K in Q2 2017. 1 fund tracked by Wall St. Rank holds FRTX as of Q4 2023.
- BlackRock reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- BlackRock sold 4,790 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $4.65K.
- BlackRock first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 29 quarters.
- BlackRock's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $879K in Q2 2017.
- 1 fund tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2023.
Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.